PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 65 filers reported holding PROQR THRAPEUTICS N V in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | -68.1% | 110,552 | +228.2% | 0.00% | – |
| Q4 2021 | $270,000 | +409.4% | 33,682 | +167.5% | 0.00% | – |
| Q4 2020 | $53,000 | -40.4% | 12,591 | -32.1% | 0.00% | – |
| Q3 2020 | $89,000 | -16.8% | 18,531 | +5.1% | 0.00% | – |
| Q2 2020 | $107,000 | -23.0% | 17,624 | -30.6% | 0.00% | – |
| Q1 2020 | $139,000 | -72.5% | 25,384 | -50.2% | 0.00% | -100.0% |
| Q4 2019 | $506,000 | +49.7% | 50,990 | +137.9% | 0.00% | – |
| Q4 2018 | $338,000 | -75.3% | 21,436 | -69.7% | 0.00% | -100.0% |
| Q3 2018 | $1,368,000 | +2300.0% | 70,686 | +506.1% | 0.00% | – |
| Q1 2016 | $57,000 | -74.1% | 11,663 | -54.0% | 0.00% | – |
| Q4 2015 | $220,000 | -51.2% | 25,376 | -17.9% | 0.00% | -100.0% |
| Q3 2015 | $451,000 | -30.6% | 30,921 | -20.7% | 0.00% | 0.0% |
| Q2 2015 | $650,000 | +87.9% | 38,993 | +146.7% | 0.00% | 0.0% |
| Q1 2015 | $346,000 | – | 15,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |